Investors

Press releases

2018/09/10

Medivir appoints Dr. Linda Basse as Chief Medical Officer

Read more
2018/08/02

Investigator-initiated phase II clinical study of remetinostat started in patients with basal cell carcinoma

Read more
2018/07/27

MIV-711 osteoarthritis phase IIa extension study outcomes show continuing positive effect on joint structure

Read more

Presentations

Quarterly report presentations

Events

2018/10/26

Interim Report January - September 2018

Read more
2018/11/05

BIO Europe 2018

Read more
2019/02/14

Year End Report 2018

Read more

Corporate Governance

Medivir Corporate Governance documention.

Annual General Meeting

Documentation from Medivir's Annual General Meetings.